Citations

Clear

224 citation(s) found for "Law, R".

A soluble bi-specific fusion protein for the improved expansion of human CD8 + CAR-T cells
Law, Jaclyn C., Matus, Esther I., Mina, Pooja R., Sparkes, Amanda , Asokumar, Navin, Trottier, Shannon , Kim, Gloria B. , Garie¬¥py, Jean, Matus, Esther I., Mina, Pooja Rani , Gariépy, Jean

Mayo Clinic

No container title available | June 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.16.26355813 Get It

Abstract The success of Chimeric Antigen Receptor (CAR) T cell therapy is heavily dependent on the quality of the final cellular product. Current expansion protocols often rely on reagents that require removal from cell culture media, posing logistical challenges in manufacturing, and can also lead to terminal differentiation. Here, we evaluate the use of a soluble, bead-free T cell activator, T cell expansion protein (T-CEP), as a streamlined alternative for generating potent CAR-T cells. Human T cells were activated with T-CEP or known T cell activators (Dynabeads and TransAct) and transduced with either CD19 or interleukin-13 (IL-13) mutein (tetravariant-13; TV-13)-based CAR lentiviral vectors. Our results demonstrate that T-CEP supports robust CAR-T cell expansion and achieves transduction efficiencies comparable to commercial reagents for both types of CAR-T cells. Notably, T-CEP significantly favored the expansion of CD8 + T cells, yielding an enhanced CD27 + phenotype and a lower CD4:CD8 ratio compared to TransAct. Cytotoxicity assays confirmed that T-CEP-expanded CAR-T cells possess cytolytic function equivalent to commercial reagents for both CARs, while exhibiting lower levels of inflammatory cytokine secretion. In summary, T-CEP represents a competitive alternative to existing expansion agents, as it does not require its removal during CAR-T manufacturing and generates a CD8 + dominant, less-differentiated phenotype without compromising efficacy. Key Points T-CEP is a soluble, bead-free activator that streamlines CAR-T manufacturing by eliminating the need for reagent removal from cultures. T-CEP consistently yields a desirable CD27 + CD8 + phenotype with a moderate inflammatory profile compared to industry-standard expanders.
Reverse EUS-GJ: EUS guided decompression of Excluded Stomach Gastric Outlet Obstruction (eGOO) after Roux-en-Y Gastric Bypass Surgery
Valls, E Vargas, Gala, K, Ghanem, O, Abimansour, J, Han, S, Law, E, Dayyeh, B Abu, Chandrasekhara, V, Vargas, Eric J. , Ghanem, Omar M. , AbiMansour, Jad P. , Han, Samuel, Dayyeh, Barham K. Abu , Chandrasekhara, Vinay

Mayo Clinic

Endoscopy | June 5, 2026 | Volume: 58 | Issue: S 03 | Pages: S809-S810

10.1055/s-0046-1822242 Get It

Contractility patterns on functional lumen imaging probe (FLIP) prior to peroral endoscopic myotomy predict outcomes in achalasia
Perananthan, V, Chhoda, A, Velasquez, L E Ospina, Song, L M Wong Kee, Law, R, Codipilly, D, Snyder, D, Leggett, C L, Alexander, J, Ravi, K, Perananthan, Varan , Velasquez, Luis E. Ospina, Codipilly, Don C. , Leggett, Cadman L. , Ravi, Karthik

Mayo Clinic

Endoscopy | June 5, 2026 | Volume: 58 | Issue: S 03 | Pages: S12-S12

10.1055/s-0046-1820656 Get It

Extending Hilton’s Law Beyond Nerves to Blood Vessels
Maldonado, Andres A. , Tubbs, R Shane, Spinner, Robert J., Spinner, Robert J.

Mayo Clinic

Plastic & Reconstructive Surgery | May 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/prs.0000000000013236 | PMID 42202265 Get It

Difficulties in Honoring Patient Requests for Hospice when Relying on Surrogate Decision-Makers: A Case Study
Meyer, Leigh, White, Lexi C., Moss, Mateo, Villanueva, Mark, Ingall, Timothy J., Guthrie, R , Murphy, Tyler, Trost, Lisa , Frase, Beverly, Collura, Christopher A., Meltzer, Ellen C. , Villanueva, Mark N, Meyer, Leigh , Guthrie, Richard V, Trost, Lisa, Collura, Christopher A.

Mayo Clinic

Journal of Law, Medicine & Ethics | May 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-4

10.1017/jme.2026.10251 | PMID 42138039 Get It

Abstract Honoring a patient’s wishes for end-of-life care can be challenging if the patient loses decision-making capacity and the identified alternate decision-maker will not respect the patient’s wishes. This article discusses how to proceed ethically and legally when the alternate decision-maker and care team disagree about respecting a patient’s end-of-life preferences.
Distinguishing Inverted Sinonasal Papilloma and Respiratory Epithelial Adenomatoid Hamartoma: A Single Institution Case Series
Swisher, Austin R. , Razmi, Samuel E., Sramek, Michael T. , Gomes, Pedro L., Schmitt, Alessandra, Miglani, Amar , Lal, Devyani, Marino, Michael J. , Razmi, Samuel E. , Eells, Annica C. , Razmi, Samuel , Swisher, Austin R , Gomes, Pedro L., Schmitt, Alessandra, Lal, Devyani

Mayo Clinic

International Journal of Surgical Pathology | May 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/10668969261446657 | PMID 42135597 Get It

Inverted sinonasal papilloma (ISP) and respiratory epithelial adenomatoid hamartoma (REAH) are sinonasal lesions with overlapping clinical, radiographic, and histologic features, making accurate diagnosis challenging. ISP is a benign but aggressive tumor with a propensity for local destruction, recurrence, and malignant transformation, whereas REAH is a hamartomatous lesion often arising in the olfactory cleft. We present four patients with lesions initially suspected to be ISP based on intraoperative frozen section but ultimately diagnosed as REAH on permanent pathology. All patients had polypoid sinonasal masses, frequently involving or adjacent to the olfactory cleft. Intraoperative frozen sections were often inconclusive or favored ISP, reflecting the difficulty of distinguishing these entities. Histologic analysis revealed that epithelial thickness served as a key morphologic feature differentiating ISP from REAH, with REAH exhibiting ciliated glandular proliferation and ISP characterized by hyperplastic epithelium with features of columnar and squamous differentiation. These patients underscore the diagnostic pitfalls of small biopsies and frozen sections, and highlight the importance of permanent specimens and collaboration with experienced pathologists. Accurate differentiation is critical, as management strategies differ substantially: ISP requires aggressive resection and long-term surveillance, while REAH may be treated with limited excision and minimal follow-up.
Public Health Limits of Medical Freedom
Hodge, James, Ghaith, Summer , Pasha, Amirala S. , Pasha, Amirala S , Hodge, James G.

Mayo Clinic

Journal of Law, Medicine & Ethics | May 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-5

10.1017/jme.2026.10265 | PMID 42130399 Get It

Abstract Through emerging interpretations of individual “medical freedoms,” a panoply of state legislative bills seeks to undermine long-standing public health and health care requirements including recommendations to test, screen, treat, and vaccinate persons. To the extent these bills could upend decades of laws and policies protecting individual and communal health, especially among vulnerable individuals, they threaten the health — and freedoms — of all persons.
Primary Cilia Are Required for Efficient BMP Signaling in Traumatic Heterotopic Ossification
Yuan, Xinyuan, Toutounchi, Saman , Law, Susan F., Achudhan, David , Chandra, Abhishek , He, Kai, Cao, Yingshu , Pignolo, Robert J. , Wang, Haitao , Wang, Haitao , Chandra, Abhishek , Hu, Jie

Mayo Clinic

Biomedicines | March 19, 2026 | Volume: 14 | Issue: 3 | Pages: 712

10.3390/biomedicines14030712 | PMID 41898356 Get It

Background/Objectives: Heterotopic ossification (HO), the aberrant formation of bone within soft tissues, arises either from rare genetic mutations or more commonly from traumatic insults. It is a major cause of morbidity not only in individuals harboring causative mutations, but also in those undergoing musculoskeletal surgery or trauma and in soldiers sustaining blast or burn injuries. Bone morphogenetic protein (BMP) signaling is a central driver of both hereditary and acquired forms of HO. Primary cilia are nonmotile, antenna-like organelles that extend from the cell surface and serve as crucial sensory and signaling hubs by concentrating key pathway components within a confined volume at the ciliary tip. However, their functional role in the pathogenesis of traumatic HO remains poorly understood. Methods: We investigate the role of primary cilia in traumatic HO using a genetically modified mouse model and cellular model. Results: We demonstrate that BMP signaling is attenuated when primary cilia function is disrupted. Both ciliation frequency and ciliary length were reduced in Scleraxis-CreERT2; Intraflagellar transport 88 floxed/floxed (Scx-CreERT2;Ift88fl/fl) tenocytes. Deletion of Ift88 effectively suppressed pathological BMP signaling and inhibited HO formation. Conclusions: These findings establish that functional primary cilia are required for traumatic HO development and highlight ciliary regulation as a potential therapeutic avenue for preventing or mitigating post-traumatic HO.